Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

Share Price Information for IQ-AI (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.10
Bid: 1.00
Ask: 1.20
Change: -0.05 (-4.35%)
Spread: 0.20 (20.00%)
Open: 1.15
High: 1.15
Low: 1.00
Prev. Close: 1.15
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing of Shares

15 Oct 2009 07:00

RNS Number : 7961A
Flying Brands Limited
15 October 2009
 



Flying Brands Limited ("Flying Brands" or the "Company")

Placing of Shares

The Board of Flying Brands is pleased to announce that it has raised £1.76 million by way of a Placing ("the Placing") with new and existing shareholders of 2,344,582 new units (each unit comprising one ordinary share of one pence in the Company and one 'A' ordinary share in Flying Brands Holdings (UK) plc) at 75 pence per unit. The placing was arranged jointly by Singer Capital Markets and Liberum Capital.

The new funds will be used to repay a part of the Company's outstanding debt.

The Placing is unconditional save as to admission of the new units to trading. Application will be made to the UK Listing Authority and to the London Stock Exchange for these units to be admitted to the Official List and to trading on the London Stock Exchange's Main Market for listed securities and it is expected that dealings will commence at 8:00am on 20th October 2009.

The new units will rank parri passu in all respects with the existing issued units in the Company.

Following this issue, the Company's issued capital at 20 October 2009 will consist of 27,873,735 units with voting rights (one vote per unit).  The Company does not hold any units in Treasury. Therefore, the total number of units in the Company with voting rights is 27,873,735.

The above figure of 27,873,735 units may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Service Authority's Disclosure and Transparency Rules.

Enquiries:

Flying Brands Limited
0844 884 6465
Stephen Cook, Chief Executive Officer
 
Anthony Gee, Finance Director
 
 
 
Singer Capital Markets Ltd
0203 205 7500
Jeff Keating, Corporate Finance
 
Nick How, Corporate Finance
 
 
 
Liberum Capital Limited
020 3100 2000
Chris Bowman, Corporate Finance
 
Tom Fyson, Corporate Finance
 
 
 
Smithfield Consulting
020 7360 4900
John Kiely
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIILFVRIFLSLIA
Date   Source Headline
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.